摘要 |
The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity. |
申请人 |
GTX, INC.;DALTON, JAMES, T.;MILLER, DUANE, D.;MOHLER, MICHAEL, L.;WU, ZHONGZHI;HONG, SEOUNG-SOO;SRIVASTAVA, DEVESH |
发明人 |
DALTON, JAMES, T.;MILLER, DUANE, D.;MOHLER, MICHAEL, L.;WU, ZHONGZHI;HONG, SEOUNG-SOO;SRIVASTAVA, DEVESH |